Europe — EMA

Oxaliplatin Teva

Oxaliplatin, the active ingredient in Oxaliplatin Teva, is a platinum compound presented as a sterile powder for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Teva, is a platinum compound presented as a sterile powder for intravenous infusion use. It is employed in the treatment of colorectal cancer and other solid tumours in adult patients. GNH USA supplies Oxaliplatin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliplatin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Teva is a platinum‑based chemotherapy agent used in the management of cancers that arise from the gastrointestinal tract and related pathways.

- Colorectal cancer: Improves the overall treatment outcome by enhancing response to combination chemotherapy. - Gastric cancer: Contributes to tumour shrink when used with other agents. - Pan‑Sov t S S S pan S t S t S S S S S S S S S S S S S S S S S S S S S S S S S S S S - -

What are the side effects of Oxaliplatin?

Oxaliplatin … … … … … … … …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →